Search Results - "Reyes, Janette T."

Usefulness of the Right Ventricular Systolic to Diastolic Duration Ratio to Predict Functional Capacity and Survival in Children With Pulmonary Arterial Hypertension by Alkon, Jaime, MD, Humpl, Tilman, MD, Manlhiot, Cedric, BSc, McCrindle, Brian W., MD, Reyes, Janette T., NP, Friedberg, Mark K., MD

“…The objective of this study was to investigate the systolic to diastolic duration ratio (S:D ratio) in children with pulmonary arterial hypertension (PAH) and…”
Get full text

Safety of maximal cardiopulmonary exercise testing in pediatric patients with pulmonary hypertension by Smith, Gareth, Reyes, Janette T, Russell, Jennifer L, Humpl, Tilman

“…Maximal cardiopulmonary exercise testing (CPX) is valuable to quantifying functional capacity in patients with pulmonary hypertension (PH), but information on…”
Get more information

Pharmacokinetic and Hemodynamic Responses to Oral Sildenafil During Invasive Testing in Children With Pulmonary Hypertension by Apitz, Christian, MD, Reyes, Janette T., RN, Holtby, Helen, MD, Humpl, Tilman, MD, Redington, Andrew N., MD

“…Objectives The purpose of our study was to characterize the hemodynamic and corresponding pharmacokinetic responses to a single dose of oral sildenafil by…”
Get full text

Resolution of Periodic Breathing in a Child with Idiopathic Pulmonary Arterial Hypertension by Reyes, Janette T., Humpl, Tilman, Khayat, Abdullah, Bin-Hasan, Saadoun, Al-Saleh, Suhail

“…Central sleep apnea (CSA) and periodic breathing are unusual findings described in pediatric patients with congestive heart failure. However, CSA has not been…”
Get full text

Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension : Twelve-month clinical trial of a single-drug, open-label, pilot study by HUMPL, Tilman, REYES, Janette T, HOLTBY, Helen, STEPHENS, Derek, ADATIA, Ian

“…Pulmonary arterial hypertension (PAH) is a progressive and fatal disease. Sildenafil is a type 5 phosphodiesterase inhibitor and pulmonary vasodilator…”
Get full text

Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children by Pelland‐Marcotte, Marie‐Claude, Humpl, Tilman, James, Paula D., Rand, Margaret L., Bouskill, Vanessa, Reyes, Janette T., Bowman, Mackenzie L., Carcao, Manuel D.

“…Summary Acquired von Willebrand syndrome (AVWS) is reported in high‐flow high‐shear congenital cardiac disorders. We hypothesized that the narrowed pulmonary…”
Get full text

Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease by Humpl, Tilman, Reyes, Janette T, Erickson, Simon, Armano, Ruth, Holtby, Helen, Adatia, Ian

“…We hypothesised that sildenafil would improve hemodynamics in children with pulmonary hypertension and attenuate rebound pulmonary hypertension after inhaled…”
Get more information

Nebulized therapies for childhood pulmonary hypertension: An in vitro model by Katz, Sherri L., Adatia, Ian, Louca, Emily, Leung, Kitty, Humpl, T., Reyes, Janette T., Coates, Allan L.

“…Objectives Sildenafil, tezosentan, and prostacyclin reduce pulmonary vascular pressures in pulmonary hypertension, but have potential to vasodilate the…”
Get full text

Resolution of Periodic Breathing in a Child with Idiopathic Pulmonary Arterial Hypertension by Bin-Hasan, Saadoun, Khayat, Abdullah, Humpl, Tilman, Reyes, Janette T, Al-Saleh, Suhail

Get full text